Skip to content
Screener

Total Revenue at other companies

Baxter International logo
Baxter InternationalBAX
$2.7B+2.9%
Boston Scientific logo
Boston ScientificBSX
$5.44B+7.5%
Kestra Medical Technologies logo
Kestra Medical TechnologiesKMTS
$28.64M+66.2%
Owlet logo
OwletOWLT
$22.46M+6.4%
CeriBell, Inc. logo
CeriBell, Inc.CBLL
$26.49M+29.3%
Medtronic logo
MedtronicMDT
$9.81B+9.9%

Segments

By product

See full
Contracted third-party payors$113.78M+16.4%
CMS$58.55M
Customer A$37.78M+18.7%
Non-contracted third-party payors$14.06M+11.1%

Other financials

Income statement

See full
Gross profit$163.2M+22.8%
Operating income-$2.5M+86.4%
Net income-$381.0K+97.3%
EPS (diluted)-$0.01+97.7%

Balance sheet

See full
Cash & equivalents$255.0M-19.7%
Total debt$76.3M-12.1%
Total equity$186.0M+79.4%
Total assets$1.1B+13.4%

Cash flow

See full
Operating cash flow$51.1M+84.7%
CapEx$13.6M+30.8%
Free cash flow$37.5M+117%

Valuation

See full
Market cap$4.21B-16.0%
Enterprise value$4.03B-15.7%
P/S5.1×-2.5×

Profitability

See full
Gross margin71.5%+1.7pp
Operating margin-3.3%-1.5pp
Net margin-7.3%-3.1pp
FCF margin4.7%

Returns & leverage

See full
Return on equity-53.1%-17.4pp
Debt / equity0.4×-0.4×
Current ratio3.9×-1.2×

Where this comes from

Reported directly by iRhythm Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: iRhythm Holdings, Inc.’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 5:21 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001388658-26-000072
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
(unaudited)
Revenue, net$224,172$186,687$423,562$345,364
Cost of revenue60,96753,830119,004103,291
Gross profit163,205132,857304,558242,073
Operating expenses:
Research and development19,84321,01241,20142,531
Acquired in-process research and development2991,6985951,994
Selling, general and administrative131,655126,376267,539246,333

Item 1. Financial Statements (Unaudited):

FAQ

What is iRhythm Holdings, Inc.'s total revenue?
iRhythm Holdings, Inc. (IRTC) reported total revenue of $224.17M in Q2 2026.
How has iRhythm Holdings, Inc.'s total revenue changed year-over-year?
iRhythm Holdings, Inc.'s total revenue increased by 20.1% year-over-year, from $186.69M to $224.17M.
What is the long-term trend for iRhythm Holdings, Inc.'s total revenue?
Over 4 years (2021 to 2025), iRhythm Holdings, Inc.'s total revenue has grown at a 23.3% compound annual growth rate (CAGR), from $322.83M to $747.14M.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Ask your AI about iRhythm Holdings, Inc.'s total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude